Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience

Louisa E. Chapman, Gregory J. Mertz, Clarence J. Peters, Heidi M. Jolson, Ali S. Khan, Thomas G. Ksiazek, Frederick T. Koster, Kenneth F. Baum, Pierre E. Rollin, Andrew T. Pavia, Robert C. Holman, John C. Christenson, Phillip J. Rubin, Rachel E. Behrman, Linda J. Wilson Bell, Gary L. Simpson, Ramses F. Sadek

Research output: Contribution to journal › Article › peer-review